1. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial ofintravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected myocardial infarction: ISIS-2;Lancet,1988
2. Anaphylactic reaction to streptokinase with first exposure: case report and review of the literature;Bednarczyk, E.M.; Sherlock, S.C.; Farah, M.G.; Green, J.A.;Drug Intell Clin Pharm,1989
3. Multiple microemboli after disintegration ofclot during thrombolysis for acute myocardial infarction;Stafford, P.J.; Strachan, C.J.L.; Vincent, R.; Chamberlain, D.A.;Br MedJ,1989
4. Cholesterol embolization syndrome. Occurrence after intravenous streptokinase therapy for myocardial infarction;Schwartz, M.W.; McDonald, G.;JAMA
5. Cholesterol embolism in a renal graft after treatment with streptokinase;Pirson, Y.; Honhon, B.; Cosyns, J.P.; van Ypersele, C.;Br Med J